Glatiramer acetate‐specific antibody titres in patients with relapsing ? remitting multiple sclerosis and in experimental autoimmune encephalomyelitis

首页> 外文期刊>Scandinavian journal of immunology. >Glatiramer acetate‐specific antibody titres in patients with relapsing ? remitting multiple sclerosis and in experimental autoimmune encephalomyelitis

【24h】

Glatiramer acetate‐specific antibody titres in patients with relapsing ? remitting multiple sclerosis and in experimental autoimmune encephalomyelitis

机译：翻新的患者的醋酸乙酸乙酸特异性抗体滴度？依赖多发性硬化和实验性自身免疫性脑肌炎

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Scandinavian journal of immunology. 》 |2018年第1期| 共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Glatiramer acetate‐specific antibody titres in patients with relapsing ? remitting multiple sclerosis and in experimental autoimmune encephalomyelitis [J] . Scandinavian journal of immunology. . 2018 ,第1期

机译：翻新的患者的醋酸乙酸乙酸特异性抗体滴度？依赖多发性硬化和实验性自身免疫性脑肌炎
2. Serious Autoimmune Diseases in Patient Treated with Glatiramer-Acetate for Relapsing-Remitting Multiple Sclerosis - Case Report [J] . Hradilek Zapletalova, Woznicova Zeman Multiple sclerosis: clinical and laboratory research . 2017 ,第2期

机译：患者治疗的严重自身免疫疾病 - 醋酸乙酸酯进行复发 - 延长多发性硬化 - 病例报告
3. Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study [J] . Khan Omar, Rieckmann Peter, Boyko Alexey, Multiple sclerosis: clinical and laboratory research . 2017 ,第6期

机译：三次每周给药方案的疗效和安全性醋酸三次醋酸多发性硬化症患者的疗效和安全性：Glatamer乙酸盐低频管理的3年结果开放标签扩展研究
4. Nanomaterials for immunotherapy against multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) [C] . Alireza Hassani Najafabadi, Rui Kuai, Anna Schwendeman, Society for Biomaterials annual meeting and exposition . 2018

机译：纳米材料用于多发性硬化/实验性自身免疫性脑脊髓炎（EAE）的免疫治疗
5. Development of potential biomarkers to forecast treatment response and clinical relapses of multiple sclerosis by investigating the CNS-specific proteome fingerprint of experimental autoimmune encephalomyelitis [D] . Raphael, Itay 2016

机译：通过研究实验性自身免疫性脑脊髓炎的中枢神经系统特异性蛋白质组指纹图谱，开发潜在的生物标记物以预测多发性硬化症的治疗反应和临床复发
6. The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients [O] . Damiano M. Rovituso, Cathrina E. Duffy, Michael Schroeter, -1

机译：复发性多发性硬化症患者的脑抗原特异性B细胞反应与醋酸格拉替雷的反应性相关
7. Interferon-beta, but not Glatiramer Acetate treatment induces gender-specific increase in BDNF serum levels in relapsing-remitting multiple sclerosis female patients [O] . Arianna Sartori, Giuliana Metelli, Alessio Polacchini, 2019

机译：干扰素β，但不是Glatizamer醋酸酯治疗在复发依赖于复发多发性硬化女性患者的BDNF血清水平中诱导性别特异性增加

Glatiramer acetate‐specific antibody titres in patients with relapsing ? remitting multiple sclerosis and in experimental autoimmune encephalomyelitis

著录项

相似文献

相关主题

期刊订阅